Novartis (NVS) News Today $97.51 -0.35 (-0.36%) As of 01/17/2025 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Greece Prosecutes Novartis Graft Probe WitnessesJanuary 20 at 2:46 PM | barrons.comWhat is Zacks Research's Estimate for Novartis Q1 Earnings?January 20 at 1:54 AM | americanbankingnews.comZacks Research Has Negative Outlook for Novartis Q1 EarningsNovartis AG (NYSE:NVS - Free Report) - Equities research analysts at Zacks Research dropped their Q1 2026 earnings estimates for Novartis in a report issued on Wednesday, January 15th. Zacks Research analyst E. Bagri now anticipates that the company will earn $2.07 per share for the quarter, downJanuary 20 at 1:52 AM | marketbeat.comNovartis files lawsuit against Biden administration over payment termsJanuary 17 at 7:26 PM | markets.businessinsider.comBoston Common Asset Management LLC Decreases Stake in Novartis AG (NYSE:NVS)Boston Common Asset Management LLC lessened its stake in shares of Novartis AG (NYSE:NVS - Free Report) by 5.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 156,774 shares of the company's stock after selling 9,399 shares during theJanuary 17 at 10:05 AM | marketbeat.comFY2025 EPS Estimates for Novartis Boosted by Zacks ResearchNovartis AG (NYSE:NVS - Free Report) - Zacks Research increased their FY2025 earnings per share estimates for Novartis in a research report issued to clients and investors on Wednesday, January 15th. Zacks Research analyst E. Bagri now anticipates that the company will post earnings of $8.33 perJanuary 17 at 7:55 AM | marketbeat.comRitholtz Wealth Management Sells 3,840 Shares of Novartis AG (NYSE:NVS)Ritholtz Wealth Management lessened its holdings in Novartis AG (NYSE:NVS - Free Report) by 4.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 92,473 shares of the company's stock after selling 3,840 shares during the quarter. RitholJanuary 17 at 6:07 AM | marketbeat.comNovartis AG (NYSE:NVS) Shares Acquired by Park Avenue Securities LLCPark Avenue Securities LLC boosted its stake in Novartis AG (NYSE:NVS - Free Report) by 31.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 43,127 shares of the company's stock after acquirinJanuary 17 at 4:10 AM | marketbeat.comAppeals court lifts halt on generic Entresto launch: reportJanuary 16, 2025 | msn.comUS appeals court lifts pause on generic version of Novartis' EntrestoJanuary 16, 2025 | reuters.comFederal court temporarily blocks generic Entresto: reportJanuary 16, 2025 | seekingalpha.comFlywheel Private Wealth LLC Purchases New Shares in Novartis AG (NYSE:NVS)Flywheel Private Wealth LLC purchased a new position in Novartis AG (NYSE:NVS - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 2,797 shares of the company's stock, valued at approximately $January 16, 2025 | marketbeat.comNovartis loses emergency bid to block Entresto generic in USJanuary 15, 2025 | reuters.comNovartis AG (NVS) JPMorgan 43rd Annual Healthcare Conference (Transcript)January 15, 2025 | seekingalpha.comNovartis AG (NVS) J.P. Morgan 43rd Annual Healthcare Conference (Transcript)January 14, 2025 | seekingalpha.comEastern Bank Cuts Position in Novartis AG (NYSE:NVS)Eastern Bank decreased its stake in Novartis AG (NYSE:NVS - Free Report) by 46.2% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 92,566 shares of the company's stock after selling 79,381 shares during the quarter. Eastern Bank's holdings iJanuary 13, 2025 | marketbeat.comNovartis Entresto U.S. patent upheld by Court of AppealsJanuary 13, 2025 | markets.businessinsider.comUS Court of Appeals upholds Novartis Entresto patentJanuary 13, 2025 | msn.comAgate Pass Investment Management LLC Invests $702,000 in Novartis AG (NYSE:NVS)Agate Pass Investment Management LLC purchased a new stake in shares of Novartis AG (NYSE:NVS - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 7,215 shares of the company's stock, valued at approximately $702,000.January 13, 2025 | marketbeat.comNovartis Pharma AG: Novartis Entresto US patent upheld by US Court of AppealsJanuary 13, 2025 | finanznachrichten.deNovartis: Entresto US Patent Upheld By US Court Of AppealsJanuary 13, 2025 | markets.businessinsider.comNovartis Entresto® US patent upheld by US Court of AppealsJanuary 13, 2025 | globenewswire.comNovartis AG (NYSE:NVS) Given Average Recommendation of "Reduce" by AnalystsNovartis AG (NYSE:NVS - Get Free Report) has earned an average recommendation of "Reduce" from the nine research firms that are covering the company, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation and seven have issued a hold recommendatiJanuary 12, 2025 | marketbeat.comNovartis: Explaining YE24 Loss Of Momentum, Outlining Prospects For 2025January 10, 2025 | seekingalpha.comLight Horse Therapeutics Enters Into Strategic Collaboration With NovartisJanuary 10, 2025 | businesswire.comAI, vaccine distrust, & the future of healthcare: Novartis CEOJanuary 10, 2025 | finance.yahoo.comDouglas Lane & Associates LLC Has $15.37 Million Holdings in Novartis AG (NYSE:NVS)Douglas Lane & Associates LLC decreased its holdings in shares of Novartis AG (NYSE:NVS - Free Report) by 4.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 157,974 shares of the company's stJanuary 9, 2025 | marketbeat.comCWA Asset Management Group LLC Purchases 5,164 Shares of Novartis AG (NYSE:NVS)CWA Asset Management Group LLC raised its holdings in shares of Novartis AG (NYSE:NVS - Free Report) by 20.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 30,840 shares of the company's stock after acJanuary 7, 2025 | marketbeat.comJPMorgan Chase & Co. Lowers Position in Novartis AG (NYSE:NVS)JPMorgan Chase & Co. decreased its stake in Novartis AG (NYSE:NVS - Free Report) by 1.8% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 312,076 shares of the company's stock after selJanuary 7, 2025 | marketbeat.comNovartis Says Drug Helps Children With Spinal Atrophy in StudyDecember 31, 2024 | msn.comNovartis reports Phase 3 STEER study met primary endpointDecember 31, 2024 | markets.businessinsider.comNovartis reports positive results for intrathecal ZolgensmaDecember 31, 2024 | msn.comNovartis gene therapy helps children with rare muscle disorder in studyDecember 30, 2024 | reuters.comNovartis intrathecal onasemnogene abeparvovec Phase III study meets primary endpoint in children and young adults with SMADecember 30, 2024 | globenewswire.comNovartis AG (NVS): Among the Cheap Healthcare Stocks to Buy Heading Into 2025December 28, 2024 | insidermonkey.comNovartis to face whistleblower case on MS drug kickbacks: reportDecember 27, 2024 | msn.comNovartis must face claims it paid kickbacks to promote MS drug, US appeals court rulesDecember 27, 2024 | reuters.comFebruary 2025 Options Now Available For Novartis (NVS)December 21, 2024 | nasdaq.comAging-focused drug company lands new partner, potential half-billion-dollar payoutDecember 21, 2024 | bizjournals.comSome 330 jobs hit as Novartis closes Morphosys, WiWo reportsDecember 19, 2024 | reuters.comBioAge Labs announces multi-year collaboration with NovartisDecember 18, 2024 | markets.businessinsider.comEast Bay aging-focused drug company lands new partner, potential half-billion-dollar payoutDecember 18, 2024 | bizjournals.comNovartis AG (NVS): Among the Oversold Global Stocks to Buy Right NowDecember 18, 2024 | insidermonkey.comNovartis AG (NYSE:NVS) Receives Average Recommendation of "Reduce" from BrokeragesNovartis AG (NYSE:NVS - Get Free Report) has been given an average recommendation of "Reduce" by the nine analysts that are covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a sell rating and seven have given a hold rating to the company. The average 12-December 18, 2024 | marketbeat.comSynovus Financial Corp Has $2.20 Million Stock Holdings in Novartis AG (NYSE:NVS)Synovus Financial Corp grew its holdings in shares of Novartis AG (NYSE:NVS - Free Report) by 42.7% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 19,157 shares of the company's stock after buying an additional 5,December 16, 2024 | marketbeat.comFY2024 EPS Estimates for Novartis Boosted by Zacks ResearchNovartis AG (NYSE:NVS - Free Report) - Equities researchers at Zacks Research increased their FY2024 earnings per share estimates for shares of Novartis in a report released on Thursday, December 12th. Zacks Research analyst E. Bagri now forecasts that the company will earn $7.60 per share for thDecember 16, 2024 | marketbeat.comNovartis and the pan-Canadian Pharmaceutical Alliance achieve milestone agreement for PLUVICTO™December 14, 2024 | theglobeandmail.comNovartis AG (NYSE:NVS) Shares Sold by Franklin Resources Inc.Franklin Resources Inc. cut its holdings in Novartis AG (NYSE:NVS - Free Report) by 18.0% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 4,377,042 shares of the company's stock after selling 962,448 shares during the period. Franklin Resources Inc. owned abDecember 14, 2024 | marketbeat.comWorld Investment Advisors LLC Makes New $3.87 Million Investment in Novartis AG (NYSE:NVS)World Investment Advisors LLC bought a new position in Novartis AG (NYSE:NVS - Free Report) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 33,671 shares of the company's stock, valued at approximately $3,873,000. OtheDecember 14, 2024 | marketbeat.comNovartis AG (NYSE:NVS) Shares Acquired by Sanctuary Advisors LLCSanctuary Advisors LLC lifted its stake in Novartis AG (NYSE:NVS - Free Report) by 14.9% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 93,276 shares of the company's stock after acquiring an additional 12,118 shares during the quarter. SanctDecember 14, 2024 | marketbeat.com Get Novartis News Delivered to You Automatically Sign up to receive the latest news and ratings for NVS and its competitors with MarketBeat's FREE daily newsletter. Email Address NVS Media Mentions By Week NVS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVS News Sentiment▼0.470.44▲Average Medical News Sentiment NVS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVS Articles This Week▼1912▲NVS Articles Average Week Get Novartis News Delivered to You Automatically Sign up to receive the latest news and ratings for NVS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NVO News AZN News SNY News GSK News TAK News ARGX News BNTX News TEVA News BGNE News SMMT News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:NVS) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementThe #1 Coin Poised to Soar Under Trump Pro-Crypto White House could make this the investment opportunity of...Crypto 101 Media | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novartis AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Novartis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NVS Stock Alerts